RedStroke - Reducing Europe's Stroke Incidence

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1019 participants.

Also called NCT04108884

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 1,019 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04108884
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Greece, Hungary, Netherlands, Poland, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04108884. Randomized; triple masking; primary purpose screening. Start 2019-10-22 (actual); primary completion 2024-01-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RedStroke - Reducing Europe's Stroke Incidence
Acronym
RedStroke
Intervention (Device)
App measurement
Intervention (Device)
14 day Holter ECG
Lead sponsor
University Hospital, Basel, Switzerland (class: other)
Collaborator
European Union (class: other)
Collaborator
Preventicus GmbH (class: industry)

Record details

Record id
cardio:ct-nct04108884
Content hash
d0f3c954257a670fa798dc46bb29d537d97d30b7576d7da71b72703ed33abba9